Form 8-K - Current report:
SEC Accession No. 0001104659-21-062719
Filing Date
2021-05-07
Accepted
2021-05-07 06:40:30
Documents
13
Period of Report
2021-05-07
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115497d1_8k.htm   iXBRL 8-K 56735
  Complete submission text file 0001104659-21-062719.txt   285506

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elan-20210507.xsd EX-101.SCH 3899
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20210507_def.xml EX-101.DEF 27028
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20210507_lab.xml EX-101.LAB 37942
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20210507_pre.xml EX-101.PRE 25640
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2115497d1_8k_htm.xml XML 5162
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 21900146
SIC: 2834 Pharmaceutical Preparations